Biomutant has been one of the launches that has most than discussed this year. There was a lot of desire to know what the game of Thq Nordic and Experiment 101 was going to offer, but after years of waiting, the network was filled with criticism for an indie game that did not catch the expectations that many had. However, and although over time there is the one who is valuing it better, the truth is that commercial performance is being very good. The editor has given the data of the game, which has already exceeded the million copies sold **. Not bad to be on sale since May 25. In addition, they specify that the game was profitable and began to give benefits a week after its launch. Something meritor after working on the project for years. The complete investment of development and marketing, in addition to the acquisition costs of Experiment 101 and the IP recovered one week after the launch, they say from THQ in the presentation of their financial results. We must also take ...